Luprocan 22.5 mg Combipack Injection 1's
₹13120*
MRP ₹16000
18% off
₹13600*
MRP ₹16000
15% CB
₹2400 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Luprocan 22.5 mg Combipack Injection belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Luprocan 22.5 mg Combipack Injection is used in combination with other medicines to treat anaemia caused by uterine fibroids.
Luprocan 22.5 mg Combipack Injection contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.
Luprocan 22.5 mg Combipack Injection will be administered by a healthcare professional. The common side effects of Luprocan 22.5 mg Combipack Injection include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Avoid taking Luprocan 22.5 mg Combipack Injection if you are pregnant or breastfeeding. Both women and men using Luprocan 22.5 mg Combipack Injection should use effective contraception. Luprocan 22.5 mg Combipack Injection may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Luprocan 22.5 mg Combipack Injection is not recommended for children below two years of age. Luprocan 22.5 mg Combipack Injection may cause dizziness, hence drive only if you are alert.
Luprocan 22.5 mg Combipack Injection contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Luprocan 22.5 mg Combipack Injection is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Luprocan 22.5 mg Combipack Injection works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Luprocan 22.5 mg Combipack Injection reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.
If you are allergic to Luprocan 22.5 mg Combipack Injection or any other medicines, please tell your doctor. Luprocan 22.5 mg Combipack Injection is not indicated for use in pregnancy and breastfeeding women. If you are using Luprocan 22.5 mg Combipack Injection, make sure to use reliable forms of contraception. Luprocan 22.5 mg Combipack Injection may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Luprocan 22.5 mg Combipack Injection is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Luprocan 22.5 mg Combipack Injection, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Luprocan 22.5 mg Combipack Injection may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Luprocan 22.5 mg Combipack Injection. Luprocan 22.5 mg Combipack Injection can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.
Drug-Drug Interaction: Luprocan 22.5 mg Combipack Injection may interact with heart rhythm problems treating drugs (quinidine, procainamide, disopyramide, amiodarone, sotalol), steroids (dexamethasone, methylprednisolone) and antibiotics (moxifloxacin), opioid pain killers (methadone)antipsychotics and antidepressants (citalopram, escitalopram, fluoxetine, paroxetine, sertraline).
Drug-Food Interaction: No interactions found/established.
Drug-Disease Interaction: Luprocan 22.5 mg Combipack Injection should be used with caution in cases of liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels.
It is advised to get an electrocardiogram (ECG) done timely to monitor your heart health.
Prostate cancer: It is the cancer of the prostate gland (a small gland under the bladder that secretes fluid that nourishes and protects sperm) found in men. The symptoms include difficulty in urination, pain, numbness or sexual problems. It is the most common type of cancer in men.
Endometriosis: It is a disorder in which tissue lining the uterus grows outside the uterine cavity. It commonly involves ovaries, fallopian tubes and the tissue lining the pelvis. Symptoms of endometriosis include pain and irregular periods.
Precocious Puberty: Precocious puberty occurs when a child's body changes into that of an adult or experiences puberty too soon. If puberty begins before age 8 in girls and before age 9 in boys, it is considered precocious puberty. Symptoms in a girl include first period and breast development, whereas, in a boy, it causes enlarged testicles and penis, deepening voice and facial hair.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Luprocan 22.5 mg Combipack Injection to avoid unpleasant side-effects. Alcohol intake, along with Luprocan 22.5 mg Combipack Injection, may cause increased dizziness.
Pregnancy
Unsafe
Luprocan 22.5 mg Combipack Injection is a pregnancy category X drug. Luprocan 22.5 mg Combipack Injection should not be used during pregnancy because it causes harm to the fetus (newborn baby). Women of childbearing potential must use an effective method of contraception while taking Luprocan 22.5 mg Combipack Injection. Please consult your doctor if you have any concerns regarding this.
Breast Feeding
Unsafe
Luprocan 22.5 mg Combipack Injection should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers.
Driving
Caution
Luprocan 22.5 mg Combipack Injection causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Luprocan 22.5 mg Combipack Injection.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking Luprocan 22.5 mg Combipack Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking Luprocan 22.5 mg Combipack Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Caution
Luprocan 22.5 mg Combipack Injection is not recommended in children younger than two years of age and should be used with caution and only if absolutely warranted in children under 12.
Country of origin
Manufacturer/Marketer address